Concepedia

Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA)

Nathan W. Levin, Steven Fishbane, Francisco Valdés Cañedo, Steven Zeig, George M. Nassar, John Moran, Giuseppe Villa, Ulrich Beyer, Delphine Oguey

The Lancet · 2007 · 157 citations · 18 references

DOI

Concepts

References

18

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

Andrew S. Levey, Josef Coresh, Kline Bolton et al. · Data Archiving and Networked Services (DANS) · 2002 · 11.7K citations

, , +13

Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS)

Ronald L. Pisoni, Jennifer L. Bragg‐Gresham, Eric W. Young et al. · American Journal of Kidney Diseases · 2004 · 402 citations

, , +16

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients

Allen R. Nissenson, Suzanne K. Swan, Jill S. Lindberg et al. · American Journal of Kidney Diseases · 2002 · 213 citations

, , +12

CERA (Continuous Erythropoietin Receptor Activator): a new erythropoiesis-stimulating agent for the treatment of anemia.

Iain C. Macdougall · PubMed · 2005 · 194 citations

, , +10

Pharmacokinetics and Pharmacodynamics of Intravenous and Subcutaneous Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Chronic Kidney Disease

Iain C. Macdougall, Richard A. Robson, Sylvie Opatrná et al. · Clinical Journal of the American Society of Nephrology · 2006 · 188 citations

, , +15